Main constraints for RNAi induced by expressed long dsRNA in mouse cells

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• RNA interference (RNAi) is a conserved biological process for gene silencing.
• Mammalian cells possess RNAi machinery, but it primarily supports the microRNA (miRNA) pathway.
• Understanding the limitations of mammalian RNAi is crucial for therapeutic applications.

Purpose of the Study:

• To systematically analyze the bottlenecks affecting RNA interference (RNAi) efficiency in mammalian systems.
• To investigate the roles of Dicer, dsRNA structure, and cofactor proteins in RNAi efficacy.
• To explore the interplay between RNAi and microRNA pathways in mammals.

Main Methods:

• Analysis of Dicer activity and its impact on small interfering RNA (siRNA) production.
• Assessment of double-stranded RNA (dsRNA) structure effects on RNAi.
• Investigation of Dicer cofactors (TARBP2, PACT) and protein kinase R (PKR) roles.
• Examination of siRNA targeting efficiency and substrate features.

Main Results:

• The primary limitation for RNAi efficiency in mammals is the production of functional siRNAs.
• Increased expression of Dicer cofactors TARBP2 or PACT unexpectedly reduced RNAi efficiency.
• Eliminating protein kinase R had minimal impact on RNAi in fibroblasts.
• RNAi can occur effectively without high Dicer activity if the initial cleavage yields an efficient siRNA.
• Efficient mammalian RNAi utilizes substrates with features similar to microRNA precursors, suggesting pathway convergence.

Conclusions:

• Mammalian RNAi efficiency is critically dependent on siRNA production, integrating Dicer activity, dsRNA structure, and target recognition.
• The interplay between RNAi and miRNA pathways is more complex than previously understood, with potential for substrate mimicry.
• Optimized substrates for endogenous RNAi could evolve, but this may compromise antiviral RNAi effectiveness due to viral adaptation.